SCHEMBL30867996

SCHEMBL30867996

N#Cc1nc(N)ccc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.39
MBOAT4 Q96T53 1/20 0.39
PIK3CD O00329 1/20 0.37
HTT P42858 2/20 0.34
MEN1 O00255 2/20 0.32
ALOX15 P16050 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NOS2 P35228 2/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
USP8 P40818 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
ERBB2 P04626 1/20 0.32
NCF1 P14598 1/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL913934 1.00 BACE1 (0.39) BACE1MBOAT4PIK3CDHTTMEN1
SCHEMBL1006497 0.78 KDM4E (0.33) MBOAT4ALOX15ALOX12USP8ERBB2
SCHEMBL23089264 0.78 BACE1 (0.39) BACE1NOS2NOS3NOS1NCF1
SCHEMBL19715553 0.77 MBOAT4 (0.35) MBOAT4USP8ERBB2
SCHEMBL28018027 0.76 PIK3CD (0.38) BACE1MBOAT4PIK3CDNOS2NOS3
SCHEMBL15221706 0.75 BACE1 (0.37) BACE1NOS2NOS3NOS1
SCHEMBL264621 0.74 MBOAT4 (0.39) MBOAT4MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL12806576 0.74 MEN1 (0.35) MBOAT4MEN1KMT2AERBB2
SCHEMBL31661428 0.74 MBOAT4 (0.39) BACE1MBOAT4PIK3CDMEN1ALOX15
SCHEMBL17399657 0.74 NOS3 (0.52) BACE1PIK3CDHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 US disclosed
US-20250340551-A1 SMALL MOLECULE MODULATORS OF STAT6 GILEAD SCIENCES INC (US) 2025-11-06 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
CN-119948025-A Heterocyclic SIK inhibitors 辉瑞大药厂 2025-05-06 CN disclosed
WO-2024028169-A1 NOVEL SPECIFICALLY SUBSTITUTED THIOPHENOLIC COMPOUNDS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2024-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 BACE1 1655/4885MBOAT4 3462/4885PIK3CD 3891/4885
US-20250340551-A1 SMALL MOLECULE MODULATORS OF STAT6 STAT6, STAT1, STAT5B BACE1 3605/4885MBOAT4 3385/4885PIK3CD 2182/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 BACE1 1380/4885MBOAT4 4350/4885PIK3CD 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.